Full Text View
Tabular View
No Study Results Posted
Related Studies
Immunogenicity and Safety of GSK Biologicals' FluLaval® TF
This study has been completed.
Study NCT00727428   Information provided by GlaxoSmithKline

First Received on August 1, 2008.   Last Updated on June 14, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Influenza
Influenza Vaccines
Additional conditions recognized in this trial
Influenza, Human
More general conditions related to this trial
Orthomyxoviridae Infections
Respiratory Tract Diseases
Respiratory Tract Infections
RNA Virus Infections
Virus Diseases
Interventions listed in this trial
FluLaval® TF
Sponsors listed in this trial
GlaxoSmithKline


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services